Hideki Maki
Impact in
- Molecular Medicine top 2%
- Antibiotic Resistance in Bacteria
- Microbiology top 5%
- Antimicrobial Peptides and Activities
Papers in
-
- Antimicrobial Resistance in Staphylococcus 13
- Antifungal resistance and susceptibility 5
- Co-authors
- Kazuhisa Murakami (5 shared papers)Yoshinori Yamano (5 shared papers)Kenji Miura (6 shared papers)Takahiro Yamaguchi (4 shared papers)Markus Bischoff (2 shared papers)Nadine McCallum (2 shared papers)Akihito Wada (2 shared papers)Brigitte Berger‐Bächi (2 shared papers)
- Journals
- Antimicrobial Agents and Chemotherapy (7 papers)Journal of Medicinal Chemistry (4 papers)Journal of Bacteriology (3 papers)PLoS ONE (2 papers)MedChemComm (2 papers)
- Partner nations
- JapanUnited KingdomSwitzerland
In The Last Decade
Hideki Maki
44 papers receiving 799 citations
Peers
Comparison fields: 5 of 80
- Molecular Medicine 185
- Microbiology 107
- Applied Microbiology and Biotechnology 32
- Infectious Diseases 298
- Pharmacology 150
Countries citing papers authored by Hideki Maki
This map shows the geographic impact of Hideki Maki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hideki Maki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hideki Maki more than expected).
Fields of papers citing papers by Hideki Maki
This network shows the impact of papers produced by Hideki Maki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hideki Maki. The network helps show where Hideki Maki may publish in the future.
Co-authors
The 25 scholars most cited alongside Hideki Maki, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 52 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2004 | 88 | |
| 2 | 2020 | 86 | |
| 3 | 2001 | 79 | |
| 4 | 1994 | 79 | |
| 5 | 2010 | 55 | |
| 6 | 1997 | 51 | |
| 7 | 2004 | 46 | |
| 8 | 1999 | 44 | |
| 9 | 2015 | 31 | |
| 10 | 2003 | 26 | |
| 11 | 2018 | 22 | |
| 12 | 2020 | 17 | |
| 13 | 2021 | 17 | |
| 14 | 2011 | 15 | |
| 15 | 2009 | 14 | |
| 16 | 2015 | 14 | |
| 17 | Prevalence and molecular characterization of CTX-M extended-spectrum β-lactamase-producing Escherichia coli from 2000 to 2010 in Japan. | 2015 | 12 |
| 18 | 2015 | 11 | |
| 19 | 2008 | 11 | |
| 20 | 2009 | 10 |
About Hideki Maki
Hideki Maki is a scholar working on Infectious Diseases, Molecular Biology, Language and Linguistics, Epidemiology and Molecular Medicine, having authored 52 papers that have together received 839 indexed citations. Recurring topics across this work include Antimicrobial Resistance in Staphylococcus (13 papers), Syntax, Semantics, Linguistic Variation (10 papers), Antibiotic Resistance in Bacteria (9 papers), Bacterial Genetics and Biotechnology (9 papers), Antimicrobial Peptides and Activities (8 papers), Language, Discourse, Communication Strategies (6 papers), Natural Language Processing Techniques (6 papers) and Antifungal resistance and susceptibility (5 papers). The work is most often cited by research in Molecular Medicine (185 citations), Microbiology (107 citations), Applied Microbiology and Biotechnology (32 citations), Infectious Diseases (298 citations) and Pharmacology (150 citations). Hideki Maki has collaborated with scholars based in Japan, United Kingdom and Switzerland. Frequent co-authors include Kazuhisa Murakami, Yoshinori Yamano, Kenji Miura, Takahiro Yamaguchi, Markus Bischoff, Nadine McCallum, Akihito Wada, Brigitte Berger‐Bächi, Takafumi Sato and Naoki Kohira. Their work appears in journals such as Antimicrobial Agents and Chemotherapy, Journal of Medicinal Chemistry, Journal of Bacteriology, PLoS ONE and MedChemComm.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.